Drug intelligence / Profile preview

perillic acid

Development stage
Preclinical
Lead developer
NEONC Technologies
Modality
Small Molecules
Administration
Oral, Intranasal
01

Overview

**Perillic acid** is a naturally occurring monoterpenoid carboxylic acid, classified as a menthane monoterpenoid, most commonly found as a metabolite of limonene in humans and some plants such as *Perilla frutescens* and *Citrus* species[1][5][7]. It is a highly hydrophobic, practically water-insoluble solid. Perillic acid displays reported **antimicrobial** and **anticancer** activity, with suggested mechanisms partly via interference with posttranslational cysteine isoprenylation affecting small G proteins (such as p21ras), resulting in induction of apoptosis by upregulation of p21, Bax, and caspase-3[2][8]. It has been studied as an antineoplastic agent and is a known biomarker in metabolism studies, and is also suggested as a possible biomarker for Parkinson’s disease[2][8].

Other names
perillic acid(-)-perillic acidperillate(S)-(-)-perillic acid4-(prop-1-en-2-yl)cyclohex-1-ene-1-carboxylic acid4-isopropenylcyclohex-1-enecarboxylic acidp-mentha-1,8-dien-7-oic acid(S)-4-Isopropenylcyclohexene-1-carboxylic acid(4S)-4-(prop-1-en-2-yl)cyclohex-1-ene-1-carboxylic acid(S)-4-(1-methylethenyl)-1-cyclohexene-1-carboxylic acid1-cyclohexene-1-carboxylic acid 4-(1-methylethenyl)
02

Targets

GGTase I (Geranylgeranyl transferase type I)FTase (Protein Farnesyltransferase)

Beyond the preview

Go deeper on perillic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perillic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call